Literature DB >> 7746481

Apolipoprotein E type epsilon 4 allele frequency is not increased in patients with sporadic inclusion-body myositis.

C R Harrington1, J R Anderson, K K Chan.   

Abstract

The apolipoprotein E genotype was determined for 11 patients with sporadic inclusion-body myositis. Seven cases had the genotype epsilon 3/epsilon 3, the other four cases, epsilon 3/epsilon 4. The frequency of the epsilon 4 allele in this group of patients (0.182) was not significantly increased compared with elderly controls (0.147; n = 58), in contrast to Alzheimer's disease in which there was a significant increase (0.328; n = 67). The epsilon 2 allele was not found in any of the 11 sporadic inclusion-body myositis patients and its frequency was decreased in Alzheimer's disease. Despite certain pathological similarities that exist between inclusion body myositis and Alzheimer's disease, their association with particular apolipoprotein E genotypes is distinct.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7746481     DOI: 10.1016/0304-3940(94)11108-u

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  9 in total

1.  Does overexpression of betaAPP in aging muscle have a pathogenic role and a relevance to Alzheimer's disease? Clues from inclusion body myositis, cultured human muscle, and transgenic mice.

Authors:  V Askanas; W K Engel
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

Review 2.  Apolipoprotein E in Alzheimer's disease and other neurological disorders.

Authors:  Philip B Verghese; Joseph M Castellano; David M Holtzman
Journal:  Lancet Neurol       Date:  2011-03       Impact factor: 44.182

Review 3.  Inclusion body myositis.

Authors:  M J Garlepp; F L Mastaglia
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-03       Impact factor: 10.154

Review 4.  The next-generation sequencing revolution and its impact on genomics.

Authors:  Daniel C Koboldt; Karyn Meltz Steinberg; David E Larson; Richard K Wilson; Elaine R Mardis
Journal:  Cell       Date:  2013-09-26       Impact factor: 41.582

5.  Inclusion body myositis-like phenotype induced by transgenic overexpression of beta APP in skeletal muscle.

Authors:  Michael C Sugarman; Tritia R Yamasaki; Salvatore Oddo; Julio C Echegoyen; M Paul Murphy; Todd E Golde; Mehrdad Jannatipour; Malcolm A Leissring; Frank M LaFerla
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-23       Impact factor: 11.205

6.  Targeted sequencing and identification of genetic variants in sporadic inclusion body myositis.

Authors:  Conrad C Weihl; Robert H Baloh; Youjin Lee; Tsui-Fen Chou; Sara K Pittman; Glenn Lopate; Peggy Allred; Jennifer Jockel-Balsarotti; Alan Pestronk; Matthew B Harms
Journal:  Neuromuscul Disord       Date:  2015-01-06       Impact factor: 4.296

7.  Amyloid-beta deposition in skeletal muscle of transgenic mice: possible model of inclusion body myopathy.

Authors:  K Fukuchi; D Pham; M Hart; L Li; J R Lindsey
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

8.  How citation distortions create unfounded authority: analysis of a citation network.

Authors:  Steven A Greenberg
Journal:  BMJ       Date:  2009-07-20

Review 9.  Sporadic inclusion body myositis: the genetic contributions to the pathogenesis.

Authors:  Qiang Gang; Conceição Bettencourt; Pedro Machado; Michael G Hanna; Henry Houlden
Journal:  Orphanet J Rare Dis       Date:  2014-06-19       Impact factor: 4.123

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.